Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$1,446,381
-4.79%
Shares
Shares Volume: 51,145 Shares
Average Share Price: $28.28
INSIDER
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER (Officer)
reported on Oct 10 2024
traded on Oct 8 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,016,035 |
| PURCHASES/SALES 1Y | 0 / 17 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $296,189.61 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 92 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $900,622.44 |
| COMPANY PREVIOUS TRADES |